MEET NADMED TEAM
The most accurate and advanced method to measure all four NAD types and glutathione
NADMED provides measuring kits for clinical laboratories and laboratory services to meet research and clinical needs.
Measure from blood
Highest accuracy
Unprecedented speed
Substantial savings
NADMED vs. other methods
Trusted by
Over
companies / organisations
In more than
countries
Conducted already
NADMED measurements worldwide
Products & Services
CE-marked blood and RUO tissue / cell kits
Kits to measure NADs from any sample type
LABORATORY SERVICE
Laboratory service to support research and drug development
Science Behind NADMED
After years of study and development, NADMED brings to market a reliable yet simple technology for extracting and measuring all four NADs and two glutathiones. The technology is based on an accurate colorimetric quantification that can be performed even from a minuscule amount of blood. The NADMED method’s key advantage is that it can measure metabolites individually, unlike any other method. The NADMED method is based on solid scientific research from the University of Helsinki.
“We have been in contact with NADMED since December 2020. First starting as a research collaboration, we enjoyed the fruitful scientific discussion, cooperative project planning, and data quality. After transitioning to a commercial service, we have been impressed and very satisfied with their great customer service and accessibility, prompt processing of samples, and quality of delivered data. We continue to use NADMED services as part of our clinical trial efforts and are looking forward to further scientific exchange and successful project collaboration.”
Christian Dölle, Neuro-SysMed researcher, University of Bergen and Haukeland University Hospital
“I cannot praise the NADMED team enough for their responsive, knowledgeable, and patient support during validations of the NAD+ assay. They are a great team to work with and I look forward to a long and successful partnership.”
Reshat Reshat, Director, North London Laboratories
”As the largest biological age testing laboratory in the US, we had always wanted to test for this important metabolite. However, the US market did not have an accurate lab test available. That is why we were excited to see the work and resume of NADMED. NADMED had studies showing reliability versus the gold standard of LC-MS and they had regulatory approval. Together, this allowed us to feel the testing was finally reliable enough to go to market.”
Ryan Smith, Vice President and Founder, TruDiagnostic
”We have partnered with NADMED Laboratories for the past two years, during which NADMED analyzed critical clinical trial samples for us. Our experience with NADMED’s sample handling, analysis, and data interpretation has been exemplary. NADMED colleagues’ expertise in NAD-related science has been exceptional and highly valuable to our drug development efforts. Their service has always been friendly and prompt, and the personnel at NADMED have consistently shown a high level of cooperation and remarkable flexibility when needed. Implementing NAD-metabolite measurements in our biomarker studies has contributed significantly to our ongoing efforts to bring treatment options to patients.”
Karen S Ho, Vice President, Clene Nanomedicine
NADMED Story
The demand for a quick and reliable test method has rapidly increased over the past few years as researchers have found more links between NAD levels and various diseases. The lack of a reliable, quick, and cost-effective method was the driving force in developing a new technology to answer this call, which all started in the ASW Laboratory at the University of Helsinki, Finland.
Unlock the Secrets of NADs
NADMED has developed a groundbreaking method that significantly enhances the development of research and clinical care of many medical disorders, starting with mitochondrial diseases. NAD levels are believed to correspond with several metabolic and degenerative diseases. First promising results of using NAD boosters as therapy for Parkinson’s disease and mitochondrial myopathy have been recently published.
Headlines
New website published
NADMED's new website was published in the end of June 2022. Designers' goal was to build a...
Q-NADMED receives CE-marking
The Q-NADMED Kit for blood received CE marking at the end of May. NADMED's kit is the only NAD...
New board members
NADMED's board is full of excellence. The new board members are Juha Tuominen, former CEO of HUS,...
Yes, I want a brief summary of NADMED technology in my email!
"*" indicates required fields